Clarifying the debate on population-based screening for breast cancer with mammography: A systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model

Medicine (United States)

Volumn 96, Issue 3, 2017, Pages

  Chen, Tony Hsiu Hsi ^a   Yen, Amy Ming Fang ^b   Fann, Jean Ching Yuan ^c   Gordon, Paula ^d   Chen, Sam Li Sheng ^b   Chiu, Sherry Yueh Hsia ^e   Hsu, Chen Yang ^a   Chang, King Jen ^f   Lee, Won Chul ^g   Yeoh, Khay Guan ^h   Saito, Hiroshi ⁱ   Promthet, Supannee ^j   Hamashima, Chisato ⁱ   Maidin, Alimin ^k   Robinson, Fredie ^l   Zhao, Li Zhong ^m  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c KAINAN UNIVERSITY   (Taiwan)

^d CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f CHENG CHING GENERAL HOSPITAL   (Taiwan)

^g The Catholic University of Korea   (South Korea)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ NATIONAL CANCER CENTER   (Japan)

^j KHON KAEN UNIVERSITY   (Thailand)

^k University of Negeri Makassar   (Indonesia)

^l UNIVERSITI MALAYSIA SABAH   (Malaysia)

^m Research Institute of Anal and Colorectal Disease of Tianjin City   (China)

more..

Author keywords

Breast cancer; Heterogeneity; Mammography; Randomized controlled trial; Screening

Indexed keywords

AGE; BAYES THEOREM; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CAUSAL MODELING; DIAGNOSTIC ERROR; HEALTH INSURANCE; HUMAN; MAMMOGRAPHY; MASS SCREENING; META ANALYSIS; PATIENT ATTENDANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SOCIAL STATUS; SYSTEMATIC REVIEW; BREAST NEOPLASMS; HEALTH SERVICE; MORTALITY; PATIENT ATTITUDE; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; HUMANS; MAMMOGRAPHY; MASS SCREENING; MEDICAL OVERUSE; PATIENT ACCEPTANCE OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 85010366320     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005684     Document Type: Review

References (38)

1. Nyström L., Rutqvist LE, Wall S, et al Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341:973-8.
2. Independent UK Panel on Breast Cancer ScreeningThe benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380:1778-86.
3. Smith RA, Duffy SW, Gabe R, et al The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 2004; 42:793-806.
4. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355:129-34.
5. Tabár L., Vitak B, Chen T.H., et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011; 260:658-63.
6. Miller AB, Wall C, Baines C.J., et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014; 348:g366.
7. Moher D, Liberati A, Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.
8. Jadad AR, Moore RA, Carroll D, et al Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12.
9. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.
10. Congdon P. Bayesian Statistical Modelling. John Wiley & Sons Ltd, West Sussex: 2006.
11. Day NE. Estimating the sensitivity of a screening test. J Epidemiol Community Health 1985; 39:364-6.
12. Chen HH, Duffy SW, Tabár L. A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. Statistician 1996; 45:307-17.
13. Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approaches to randomised trials. J R Stat Soc A 1994; 157:357-416.
14. Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care 2003; 26:3093-101.
15. Ness RB, Koopman JS, Roberts MS Causal system modeling in chronic disease epidemiology: a proposal. Ann Epidemiol 2007; 17:564-8.
16. Shapiro S, Venet W, Strax P., et al. Ten-to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69:349-55.
17. Shapiro S, Goldberg JD, Hutchison GB Lead time in breast cancer detection and implications for periodicity of screening. Am J Epidemiol 1974; 100:357-66.
18. Shapiro S. Periodic screening for breast cancer: the HIP randomized controlled trial. Monogr Natl Cancer Inst 1997; 22:27-30.
19. Chu KC, Smart CR, Tarone RE Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan Clinical Trial. J Natl Cancer Inst 1988; 80:1125-32.
20. Andersson I, Aspegren K, Janzon L., et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988; 297:943-8.
21. Ikeda DM, Andersson I, Wattsgard C., et al. Interval cancer in the Malmo mammographic screening trial: radiographic appearance and prognostic considerations. Am J Roentgenol 1992; 159:287-94.
22. Tabár L., Fagerberg CJ, Gad A, et al Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1:829-32.
23. Roberts MM, Alexander FE, Anderson T.J., et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990; 335: 241-6.
24. Alexander FE, Anderson TJ, Brown H.K., et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999; 353:1903-8.
25. Miller AB, Baines CJ, To T, et al Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992; 147:1459-76.
26. Miller AB, To T, Baines C.J., et al. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002; 137(5 Part 1):305-12.
27. Miller AB, Baines CJ, To T, et al Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992; 147:1477-88.
28. Miller AB, To T, Baines C.J., et al. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92:1490-9.
29. Frisell J, Lidbrink E, Hellstrom L., et al. Follow up after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997; 45:263-70.
30. Frisell J, Eklund G, Hellstrom L., et al. Analysis of interval breast carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 1987; 9:219-25.
31. Bjurstam N, Björneld L, Warwick J., et al. The Gothenburg Breast Screening Trial. Cancer 2003; 97:2387-96.
32. Bjurstam N, Björneld L, Duffy S.W., et al. The Gothenburg Breast Screening Trial: first results on mortality, incidence and mode of detection for women aged 39-49 years at randomization. Cancer 1997; 80:2091-9.
33. Moss SM, Cuckle H, Evans A., et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006; 368:2053-60.
34. Walter SD, Day NE Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol 1983; 118:865-86.
35. Tabár L., Yen AM, Wu W.Y., et al. Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J 2015; 21:13-20.
36. Goel V, Cohen MM, Kaufert P, et al Assessing the extent of contamination in the Canadian National Breast Screening Study. Am J Prev Med 1998; 15:206-11.
37. Taghipour S, Banjevic D, Miller A.B., et al. Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study. Br J Cancer 2013; 108:542-8.
38. Baines CJ. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 1994; 120:326-34.